About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Zydus Lifesciences Ltd.
BSE Code 532321
ISIN Demat INE010B01027
Book Value 143.63
NSE Code ZYDUSLIFE
Dividend Yield % 0.65
Market Cap 927948.99
P/E 36.72
EPS 25.11
Face Value 1  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Dec 2023Sep 2023Jun 2023Mar 2023
 Audited / UnAudited UnAudited UnAudited UnAudited Audited
Net Sales 23713.00 21593.00 29557.00 25793.00
Total Expenditure 16890.00 15966.00 18147.00 18068.00
PBIDT (Excl OI) 6823.00 5627.00 11410.00 7725.00
Other Income 1236.00 6212.00 824.00 2512.00
Operating Profit 8059.00 11839.00 12234.00 10237.00
Interest 1039.00 909.00 897.00 850.00
Exceptional Items 0 0 0 -2038.00
PBDT 7020.00 10930.00 11337.00 7349.00
Depreciation 1277.00 1249.00 1212.00 1199.00
Profit Before Tax 5743.00 9681.00 10125.00 6150.00
Tax 1239.00 1631.00 2316.00 1243.00
Provisions and contingencies 0 0 0 0
Profit After Tax 4504.00 8050.00 7809.00 4907.00
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 4504.00 8050.00 7809.00 4907.00
Equity Capital 1012.00 1012.00 1012.00 1012.00
Face Value (IN RS) 1 1 1 1
Reserves    
Calculated EPS 4.45 7.95 7.72 4.85
Calculated EPS (Annualised) 17.80 31.82 30.87 19.40
No of Public Share Holdings 253263953.00 253263953.00 253263953.00 253263953.00
% of Public Share Holdings 25.02 25.02 25.02 25.02
     
PBIDTM% (Excl OI) 28.77 26.06 38.60 29.95
PBIDTM% 33.99 54.83 41.39 39.69
PBDTM% 29.60 50.62 38.36 28.49
PBTM% 24.22 44.83 34.26 23.84
PATM% 18.99 37.28 26.42 19.02
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.